The Landscape of MET Exon 14 Skipping Mutations in Patients With Lung Cancer Identified by Next-Generation Sequencing
Introduction: MET exon 14 (METex14) skipping mutations are observed in approximately 0.9% to 4% of patients with NSCLC. This study aimed to compare the detection rates of METex14 skipping in Chinese patients with lung cancer using DNA-based next-generation sequencing (NGS) with capture-based library...
Saved in:
Main Authors: | Jia Liao, MD, Song Wu, MD, Yi Min, MD, Yiran Li, MD, Yuanhang Nie, MD, Quwen Chen, MD, Zhiliang Mao, MD, Qinglan Zong, MS, Ning Gao, MS, Ding Zhang, PhD, Weiquan Liang, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-07-01
|
Series: | JTO Clinical and Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666364325000426 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Leptomeningeal Disease with Tepotinib in a Patient with Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Presenting with Extensive Metastasis Involving Duodenum
by: Jacquelyn Shugarts, et al.
Published: (2025-06-01) -
Successful Tepotinib Treatment in MET Exon 14 Skipping Mutation‐Positive Lung Adenocarcinoma With Idiopathic Pulmonary Fibrosis Through Nintedanib Combination
by: Yoshiki Kato, et al.
Published: (2025-06-01) -
MET Exon 14 Skipping Mutations in Lung Cancer: Clinical–Pathological Characteristics and Immune Microenvironment
by: Qianqian Xue, et al.
Published: (2025-07-01) -
Possibility of exon skipping therapy for Duchenne muscular dystrophy in Russian patients: present and future
by: E. V. Zinina, et al.
Published: (2024-09-01) -
PENGARUH LATIHAN SKIPPING TERHADAP TINGKAT KONSENTRASI MAHASISWA FK UNDIP
by: Rara Badriya Agustin, et al.
Published: (2018-11-01)